AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,605,000 | +253.4% | 133,703 | +71.5% | 0.00% | +200.0% |
| Q2 2020 | $1,303,000 | +2.9% | 77,982 | -11.1% | 0.00% | 0.0% |
| Q1 2020 | $1,266,000 | -53.9% | 87,763 | +6.9% | 0.00% | -50.0% |
| Q4 2019 | $2,748,000 | +126.7% | 82,124 | +41.8% | 0.00% | +100.0% |
| Q3 2019 | $1,212,000 | +49.6% | 57,926 | +48.9% | 0.00% | – |
| Q2 2019 | $810,000 | +145.5% | 38,900 | +163.8% | 0.00% | – |
| Q1 2019 | $330,000 | +478.9% | 14,747 | +520.9% | 0.00% | – |
| Q4 2018 | $57,000 | -97.7% | 2,375 | -97.3% | 0.00% | -100.0% |
| Q3 2018 | $2,442,000 | +1528.0% | 89,528 | +1514.3% | 0.00% | – |
| Q2 2018 | $150,000 | -80.6% | 5,546 | -77.2% | 0.00% | -100.0% |
| Q1 2018 | $775,000 | -91.9% | 24,325 | -90.3% | 0.00% | -87.5% |
| Q4 2017 | $9,517,000 | +592.6% | 251,628 | +353.7% | 0.01% | +700.0% |
| Q3 2017 | $1,374,000 | +45700.0% | 55,463 | +53229.8% | 0.00% | – |
| Q2 2017 | $3,000 | -97.3% | 104 | -98.0% | 0.00% | – |
| Q1 2017 | $111,000 | +29.1% | 5,097 | +19.6% | 0.00% | – |
| Q4 2016 | $86,000 | +1333.3% | 4,262 | +907.6% | 0.00% | – |
| Q3 2016 | $6,000 | – | 423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |